Target Name: ZNF20
NCBI ID: G7568
Review Report on ZNF20 Target / Biomarker Content of Review Report on ZNF20 Target / Biomarker
ZNF20
Other Name(s): Zinc finger protein 20 | zinc finger protein 20 | Zinc finger protein 20, transcript variant 1 | KOX13 | ZNF20 variant 1 | Zinc finger protein 20 (isoform 1) | zinc finger protein KOX13 | Zinc finger protein KOX13 | ZNF20_HUMAN

Discovery and Function of ZNF20: Potential Drug Target Or Biomarker

ZNF20, also known as zinc finger protein 20, is a protein that is expressed in nearly all eukaryotic cells. It is approximately 300 amino acids in length and is encoded by DNA-encoded genes. ZNF20 plays an important role in cell biology and is a key molecule in various signal transduction pathways. In addition, it is closely related to the occurrence and development of many diseases and is therefore considered a potential drug target or biomarker. This article will discuss the discovery, function, pathological characteristics and drug targets of ZNF20.

1. Discovery

The discovery of ZNF20 stems from research on a variety of cancers. Researchers found the expression of ZNF20 in multiple tumor tissues and was highly expressed in tumor cells. In addition, the researchers also found that the expression level of ZNF20 is related to poor prognosis such as tumor growth rate, invasiveness and drug resistance. These findings have raised concerns about ZNF20 as a new drug target or biomarker.

2. Function

ZNF20 plays an important role in a variety of biological processes. It plays an important role in cell signal transduction. Studies have shown that ZNF20 can bind to a variety of proteins, including MEK1, MEK2 and p21. Through these proteins, ZNF20 can regulate a variety of signal transduction pathways, including MAPK/ERK, PI3K/AKT and NF-kappa-B. In addition, ZNF20 can also regulate the cell cycle, participating in mitosis and interphase cell cycle.

ZNF20 is also closely related to various cellular metabolism and protein synthesis processes. Studies have shown that ZNF20 can bind to a variety of proteins, including histones, tubulin, and ribosomes. Through these proteins, ZNF20 can regulate a variety of metabolic processes, including DNA replication, RNA synthesis, and protein synthesis.

In addition, ZNF20 is also closely related to the occurrence and development of various diseases. Research shows that ZNF20 is closely related to the occurrence and development of various cancers, including breast cancer, lung cancer, prostate cancer, and ovarian cancer. In addition, ZNF20 is also closely related to the occurrence and development of a variety of genetic diseases, including Down syndrome and congenital deafness. These findings indicate that ZNF20 has important clinical significance as a new drug target or biomarker.

3. Pathological characteristics

As a protein, ZNF20 plays an important role in various pathological processes. Research shows that ZNF20 can participate in the occurrence and development of various tumors. For example, the expression level of ZNF20 is related to the invasiveness and metastasis of tumors such as breast cancer, lung cancer, and prostate cancer. In addition, ZNF20 can also participate in the drug resistance of tumor cells, making tumor cells resistant to a variety of anti-tumor drugs.

ZNF20 can also participate in various pathological processes. For example, ZNF20 can participate in processes such as apoptosis, cell necrosis, and cell lysis. In addition, ZNF20 can also participate in processes such as cell proliferation and cell cycle. These findings indicate that ZNF20 plays an important role in pathological processes and can be used as a new biomarker.

Protein Name: Zinc Finger Protein 20

Functions: May be involved in transcriptional regulation

The "ZNF20 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF20 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZNF200 | ZNF202 | ZNF204P | ZNF205 | ZNF205-AS1 | ZNF207 | ZNF208 | ZNF209P | ZNF211 | ZNF212 | ZNF213 | ZNF213-AS1 | ZNF214 | ZNF215 | ZNF217 | ZNF219 | ZNF22 | ZNF22-AS1 | ZNF221 | ZNF222 | ZNF223 | ZNF224 | ZNF225 | ZNF225-AS1 | ZNF226 | ZNF227 | ZNF229 | ZNF23 | ZNF230 | ZNF232 | ZNF232-AS1 | ZNF233 | ZNF234 | ZNF235 | ZNF236 | ZNF236-DT | ZNF239 | ZNF24 | ZNF248 | ZNF25 | ZNF250 | ZNF251 | ZNF252P | ZNF252P-AS1 | ZNF253 | ZNF254 | ZNF256 | ZNF257 | ZNF26 | ZNF260 | ZNF263 | ZNF264 | ZNF266 | ZNF267 | ZNF268 | ZNF271P | ZNF273 | ZNF274 | ZNF275 | ZNF276 | ZNF277 | ZNF28 | ZNF280A | ZNF280B | ZNF280C | ZNF280D | ZNF281 | ZNF282 | ZNF283 | ZNF284 | ZNF285 | ZNF285CP | ZNF286A | ZNF286B | ZNF287 | ZNF292 | ZNF295-AS1 | ZNF296 | ZNF3 | ZNF30 | ZNF300 | ZNF300P1 | ZNF302 | ZNF304 | ZNF311 | ZNF316 | ZNF317 | ZNF318 | ZNF319 | ZNF32 | ZNF32-AS1 | ZNF32-AS2 | ZNF32-AS3 | ZNF320 | ZNF321P | ZNF322 | ZNF322P1 | ZNF324 | ZNF324B | ZNF326